Literature DB >> 17483499

WY-14,643 induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase.

Courtney G Woods1, Amanda M Burns, Blair U Bradford, Pamela K Ross, Oksana Kosyk, James A Swenberg, Michael L Cunningham, Ivan Rusyn.   

Abstract

Long-term exposure of rodents to peroxisome proliferators leads to increases in peroxisomes, hepatocellular proliferation, oxidative damage, suppressed apoptosis, and ultimately results in the development of hepatic adenomas and carcinomas. Peroxisome proliferators-activated receptor (PPAR)alpha was shown to be required for these pleiotropic responses; however, Kupffer cells, resident liver macrophages, were also identified as playing a role in peroxisome proliferators-induced effects, independently of PPARalpha. Previous studies showed that oxidants from NADPH (nicotinamide adenine dinucleotide phosphate, reduced) oxidase mediate acute effects of peroxisome proliferators in rodent liver. To determine if Kupffer cell oxidants are also involved in chronic effects, NADPH oxidase-deficient (p47(phox)-null) mice were fed 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio acetic acid (WY-14,643)-containing diet (0.1% wt/wt) for 1 week, 5 weeks, or 5 months along with Pparalpha-null and wild type mice. As expected, no change in liver size, cell replication rates, or other phenotypic effects of peroxisome proliferators were observed in Pparalpha-null mice. Through 5 months of treatment, the p47(phox)-null and wild type mice exhibited peroxisome proliferators-induced adverse liver effects, along with increased oxidative DNA damage and increased cell proliferation, a response that is potentially mediated through nuclear factor kappa B (NFkB). Suppressed apoptosis caused by WY-14,643 was dependent on both NADPH oxidase and PPARalpha. Collectively, these findings suggest that involvement of Kupffer cells in WY-14,643-induced parenchymal cell proliferation and oxidative stress in rodent liver is an acute phenomenon that is not relevant to long-term exposure, but they are still involved in chronic apoptotic responses. These results provide new insight for understanding the mode of hepatocarcinogenic action of peroxisome proliferators.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17483499     DOI: 10.1093/toxsci/kfm104

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  16 in total

1.  Evaluation of an in vitro toxicogenetic mouse model for hepatotoxicity.

Authors:  Stephanie M Martinez; Blair U Bradford; Valerie Y Soldatow; Oksana Kosyk; Amelia Sandot; Rafal Witek; Robert Kaiser; Todd Stewart; Kirsten Amaral; Kimberly Freeman; Chris Black; Edward L LeCluyse; Stephen S Ferguson; Ivan Rusyn
Journal:  Toxicol Appl Pharmacol       Date:  2010-09-24       Impact factor: 4.219

2.  Hepatocyte-specific PPARA expression exclusively promotes agonist-induced cell proliferation without influence from nonparenchymal cells.

Authors:  Chad N Brocker; Jiang Yue; Donghwan Kim; Aijuan Qu; Jessica A Bonzo; Frank J Gonzalez
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-01-12       Impact factor: 4.052

3.  PPARalpha-dependent activation of cell cycle control and DNA repair genes in hepatic nonparenchymal cells.

Authors:  Aijuan Qu; Yatrik M Shah; Tsutomu Matsubara; Qian Yang; Frank J Gonzalez
Journal:  Toxicol Sci       Date:  2010-09-02       Impact factor: 4.849

4.  PPARα activation drives demethylation of the CpG islands of the Gadd45b promoter in the mouse liver.

Authors:  Jung-Hwan Kim; Lilik Duwi Wahyudi; Kee K Kim; Frank J Gonzalez
Journal:  Biochem Biophys Res Commun       Date:  2016-05-24       Impact factor: 3.575

5.  Myeloid peroxisome proliferator-activated receptor α deficiency accelerates liver regeneration via IL-6/STAT3 pathway after 2/3 partial hepatectomy in mice.

Authors:  Guomin Xie; Yanting Song; Na Li; Zhenzhen Zhang; Xia Wang; Ye Liu; Shiyu Jiao; Ming Wei; Baoqi Yu; Yan Wang; Hua Wang; Aijuan Qu
Journal:  Hepatobiliary Surg Nutr       Date:  2022-04       Impact factor: 7.293

6.  Editor's Highlight: Mechanistic Toxicity Tests Based on an Adverse Outcome Pathway Network for Hepatic Steatosis.

Authors:  Michelle M Angrish; Charlene A McQueen; Elaine Cohen-Hubal; Maribel Bruno; Yue Ge; Brian N Chorley
Journal:  Toxicol Sci       Date:  2017-09-01       Impact factor: 4.849

7.  Time course investigation of PPARalpha- and Kupffer cell-dependent effects of WY-14,643 in mouse liver using microarray gene expression.

Authors:  Courtney G Woods; Oksana Kosyk; Blair U Bradford; Pamela K Ross; Amanda M Burns; Michael L Cunningham; Pingping Qu; Joseph G Ibrahim; Ivan Rusyn
Journal:  Toxicol Appl Pharmacol       Date:  2007-09-16       Impact factor: 4.219

8.  Epigenetic effects of the continuous exposure to peroxisome proliferator WY-14,643 in mouse liver are dependent upon peroxisome proliferator activated receptor alpha.

Authors:  Igor P Pogribny; Volodymyr P Tryndyak; Courtney G Woods; Sarah E Witt; Ivan Rusyn
Journal:  Mutat Res       Date:  2007-05-18       Impact factor: 2.433

9.  Hepatic oxidative stress activates the Gadd45b gene by way of degradation of the transcriptional repressor STAT3.

Authors:  Jung-Hwan Kim; Aijuan Qu; Janardan K Reddy; Bin Gao; Frank J Gonzalez
Journal:  Hepatology       Date:  2013-12-23       Impact factor: 17.425

Review 10.  The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions.

Authors:  J Christopher Corton; Jeffrey M Peters; James E Klaunig
Journal:  Arch Toxicol       Date:  2017-12-02       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.